InsiderTrades

Form 4 for RVMD Revolution Medicines, Inc.

Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-25 · accession 0001610717-25-000403 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-11-26 2025-11-25 RVMD GOLDSMITH MARK A See Remarks, Dir M - OptEx $4.09 +60.0K 307.9K +24% +$245.4K
DT 2025-11-26 2025-11-25 RVMD GOLDSMITH MARK A See Remarks, Dir S - Sale+OE $75.08 -60.0K 247.9K -19% -$4.50M
DMTI 2025-11-26 2025-11-25 RVMD GOLDSMITH MARK A See Remarks, Dir S - Sale+OE $75.00 -6,000 67.4K -8% -$450.0K
DT 2025-11-26 2025-11-25 RVMD GOLDSMITH MARK A See Remarks, Dir M - OptEx $0.00 -60.0K 77.7K -44% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-25 M A 60,000 $4.09 307,863 D Trust — — (F2) Includes 193,475 restricted stock units. (F4) Held by Jonathan Goldsmith Revocable Trust.
2 Common Common Stock 2025-11-25 S D 60,000 $75.08 247,863 D Trust — — (F3) This transaction was executed in multiple trades at prices ranging from $75.00 to $75.3650. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 193,475 restricted stock units. (F5) Held by Rebecca Goldsmith Revocable Trust.
3 Common Common Stock 2025-11-25 S D 3,000 $75.00 67,424 I — —
4 Common Common Stock 2025-11-25 S D 3,000 $75.00 67,424 I — —
5 Derivative Stock Option (Right to Buy) 2025-11-25 M D 60,000 $0.00 77,708 D $4.09 · 2023-03-13 to 2029-03-12 60,000 Common Stock